Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10144931 Antisense nucleic acids

Overview Structured Data Issues Contributors Activity

All edits

Edits on 30 Oct, 2024

"update inverses"

Golden AI

edited on 30 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies

Edits on 19 Jun, 2024

"update inverses"

Golden AI

edited on 19 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

Edits on 12 Jun, 2024

"update inverses"

Golden AI

edited on 12 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12005124 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 22 May, 2024

"update inverses"

Golden AI

edited on 22 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11986537 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 8 Dec, 2023

"Add patent abstract"

Golden AI

edited on 8 Dec, 2023

Edits made to:

Article (+117 characters)

Article

Patent abstract

The present invention provides an oligomer which allows exon 45 skipping in the human dystrophin gene.

Edits on 7 Dec, 2023

"update inverses"

Golden AI

edited on 7 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11833217 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 19 Oct, 2023

"update inverses"

Golden AI

edited on 19 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

Edits on 4 Oct, 2023

"update inverses"

Golden AI

edited on 4 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11771776 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 2 Oct, 2023

"Add patent inventor(s)"

Golden AI

edited on 2 Oct, 2023

Edits made to:

Infobox (+4 properties)

Infobox

Patent Inventor Names

Shin'ichi Takeda0

Yoshitsugu Aoki0

Yuichiro Tone0

Yukiko Enya0

Edits on 21 Jun, 2023

"update inverses"

Golden AI

edited on 21 Jun, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11679161 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Edits on 30 Apr, 2023

"update inverses"

Golden AI

edited on 30 Apr, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11633496 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 19 Apr, 2023

"update inverses"

Golden AI

edited on 19 Apr, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11629197 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

Edits on 23 Mar, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 23 Mar, 2023

Infobox

Patent Citations Received

‌

US Patent 11369689 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 16 Nov, 2022

"update inverses"

Golden AI

edited on 16 Nov, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11497815 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 27 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 27 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 10450568 Oligonucleotide compositions and methods thereof

Edits on 23 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 23 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 11369689 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 29 Jun, 2022

"update inverses"

Golden AI

edited on 29 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 11369689 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 16 Feb, 2022

"update inverses"

Golden AI

edited on 16 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 11248056 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 29 Jan, 2022

"update inverses"

Golden AI

edited on 29 Jan, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 10450568 Oligonucleotide compositions and methods thereof

Edits on 23 Jan, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 23 Jan, 2022

Edits made to:

Infobox (+7 properties)

‌

US Patent 10144931 Antisense nucleic acids

Infobox

Is a

Patent

Patent jurisdiction

United States Patent and Trademark Office

Patent number

10144931

Date of patent

December 4, 2018

Patent application number

15759267

Date Filed

September 15, 2016

Patent primary examiner

‌

Sean McGarry

Find more entities like US Patent 10144931 Antisense nucleic acids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API